Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer's disease
Abstract Background The complement component (3b/4b) receptor 1 gene (CR1) gene has been proved to affect the susceptibility of Alzheimer's disease (AD) in different ethnic and districts groups. However, the effect of CR1 genetic variants on amyloid β (Aβ) metabolism of AD human is still unclea...
Saved in:
Main Authors: | Xi-chen Zhu (Author), Wen-zhuo Dai (Author), Tao Ma (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease
by: Carolina A. Magalhães, et al.
Published: (2015) -
The meaning of blood and cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
by: Julita Szarpak, et al.
Published: (2020) -
Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease
by: Kwangsik Nho, et al.
Published: (2017) -
The Concentration of Memantine in the Cerebrospinal Fluid of Alzheimer's Disease Patients and Its Consequence to Oxidative Stress Biomarkers
by: Martin Valis, et al.
Published: (2019) -
Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease
by: Carmen Peña-Bautista, et al.
Published: (2020)